Aprameya Engineering P/B Ratio
Current P/B Ratio
2.88
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Aprameya Engineering P/B ratio. Aprameya Engineering (APRAMEYA) P/B ratio is 2.88 (Moderate), book value per share ₹36.84 vs Healthcare average P/B of 0.01 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see APRAMEYA screener.
Current Valuation Metrics
P/B Ratio
2.88
Current Price
₹
Book Value/Share
₹36.84
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹70 Cr
Share Capital
₹19 Cr
Reserves & Surplus
₹50 Cr
Outstanding Shares
19,000,000
Book Value per Share
₹36.84
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
0.01
Sector Median
0.61
Sector Rank
#11 of 50
Sector Percentile
22.0%
APRAMEYA P/B Ratio — Valuation Insights & Book Value Analysis
Aprameya Engineering price-to-book ratio interpretation, valuation status and historical context — current P/B 2.88 (Moderate). View Aprameya Engineering 52-week for the annual high/low range and current price position.
- Trading at premium to sector average PB of 0.01
APRAMEYA vs Healthcare Peers — P/B Ratio Comparison
Aprameya Engineering P/B 2.88 vs Healthcare average 0.01, median 0.61 — range -6.55–1.07.
Sector Average
0.01
Sector Median
0.61
Lowest P/B
-6.55
Highest P/B
1.07
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |